ANN-Powered Precision Oncology: A Comprehensive Review of Cancer Detection, Classification, and Prognosis Modeling
Keywords:
Artificial Neural Networks, Precision Oncology, Cancer Detection, Cancer Classification, Prognosis Modeling, Deep Learning, Medical Imaging, Multi-omics, Survival Prediction, Explainable AIAbstract
Artificial Neural Networks (ANNs) have revolutionized the landscape of medical diagnostics, particularly in oncology, where early and accurate detection can substantially impact patient outcomes. This paper provides a comprehensive review of the role of ANNs in precision oncology, emphasizing cancer detection, classification, and prognosis modeling. With the surge in multi-omics data, imaging modalities, and electronic health records, traditional diagnostic methods are being supplemented and sometimes replaced by data-driven approaches. ANNs, owing to their capacity for learning complex patterns, have demonstrated superior performance in tasks such as tumor identification in histopathological images, genomic data classification, and survival prediction. This review highlights key ANN architectures including Convolutional Neural Networks (CNNs), Deep Neural Networks (DNNs), and hybrid models, discussing their specific applications and performance metrics across various cancer types such as breast, lung, colorectal, and prostate cancers. The paper also explores challenges in model interpretability, data heterogeneity, and clinical integration while presenting recent advancements in explainable AI, federated learning, and transfer learning as potential solutions. A critical evaluation of publicly available datasets and the importance of cross-institutional collaborations is discussed to ensure the scalability and robustness of ANN-based solutions. By consolidating findings from recent literature, this review offers a roadmap for future research and implementation strategies in ANN-powered oncology.
Downloads
References
Esteva, A. et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118.
Coudray, N. et al. (2018). Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning. Nature Medicine, 24(10), 1559–1567.
Mobadersany, P. et al. (2018). Predicting cancer outcomes from histology and genomics using convolutional networks. PNAS, 115(13), E2970–E2979.
Ching, T. et al. (2018). Opportunities and obstacles for deep learning in biology and medicine. Journal of the Royal Society Interface, 15(141), 20170387.
Huang, G. et al. (2017). Densely connected convolutional networks. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition (pp. 4700–4708).
Katzman, J. L. et al. (2018). DeepSurv: Personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Medical Research Methodology, 18(1), 24.
Ghosal, S. et al. (2020). Explainable AI for histopathological diagnosis: Trends and challenges. IEEE Access, 8, 146648–146666.
Sheller, M. J. et al. (2020). Federated learning in medicine: Facilitating multi-institutional collaborations without sharing patient data. Scientific Reports, 10(1), 12598.
Yasaka, K., & Abe, O. (2018). Deep learning and artificial intelligence in radiology: Current applications and future directions. PLOS Medicine, 15(11), e1002707.
Wang, X. et al. (2021). Pathomic Fusion: An integrated framework for fusing histopathology and genomic features for cancer diagnosis and prognosis. IEEE Transactions on Medical Imaging, 40(4), 978–989.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.